Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
申请人:Bayer HealthCare LLC
公开号:US08338594B2
公开(公告)日:2012-12-25
This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly Cancer.
PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE
申请人:Magnuson Steven
公开号:US20110021518A1
公开(公告)日:2011-01-27
This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly Cancer.
[EN] PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE<br/>[FR] DÉRIVÉS DE PYRROLOTRIAZINE UTILES POUR TRAITER LE CANCER PAR INHIBITION DE LA KINASE AURORA
申请人:BAYER PHARMACEUTICALS CORP
公开号:WO2007064932A2
公开(公告)日:2007-06-07
[EN] This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly Cancer [FR] L'invention concerne de nouveaux composés et des procédés pour leur préparation, des méthodes destinées à traiter des maladies, et notamment le cancer, et consistant à administrer lesdits composés, ainsi que des procédés de fabrication de compositions pharmaceutiques pour le traitement ou la prévention de maladies, et notamment du cancer.